Source: Eur Respir J, 51 (3) 1800276; 10.1183/13993003.00276-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sébastien Bonnet, Olivier Boucherat. The ROS controversy in hypoxic pulmonary hypertension revisited. Eur Respir J, 51 (3) 1800276; 10.1183/13993003.00276-2018

Member's Comments

No comment yet.

Related content which might interest you: Increase of oxidative stress and pulmonary arterial inflammatory remodeling under high-flow conditions in experimental pulmonary hypertension Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that? Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017 Year: 2017 Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms Source: Eur Respir J 2008; 32: 1639-1651 Year: 2008 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Pulmonary hypertension in COPD Source: Eur Respir J 2008; 32: 1371-1385 Year: 2008 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011 Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006 Hypoxic pulmonary vasoconstriction: clinical implications Source: Eur Respir J 2016; 47: 31-34 Year: 2016 Oxidative stress in patients with COPD and pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 161s Year: 2006 The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg? Source: Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020 Year: 2020